Chronic pancreatitis: what should be considered in diagnosis, treatment, and prognosis

Author: T. N. Khristich Yuriy Fedkovych Chernivtsi National University, Ukraine Summary The aim of the

Prognosismodifying therapy in patients with CAD: how to optimize treatment?

Authors: Khanyukov A.A., Professor, Doctor of Medical Sciences, Head of the Department of Internal Medicine,

Clinical case of acute pancreatitis associated with COVID-19 vaccination

Authors: N. B. Gubergrits1, Yu. M. Alkhazov2, N. A. Abdullaeva3 1 Into Sana” Multifield Clinic,

Diaphragmatic hernia: mechanisms of formation, clinic, treatment tactics

Authors: N. B. Gubergrits, N. V. Byelyayeva, A. Ye. Klochkov, G. M. Lukashevich, P.G. Fomenko,

Experience of using pantoprazole in the complex therapy of diseases of the digestive tract of different age groups

Authors: Iu.V. Marushko, A.O. Asonov, O.O. Bogomolets National Medical University, Kyiv Summary Gastroesophageal reflux disease

Modern approaches to the treatment and prevention of gastrointestinal bleeding associated with NSAID gastropathy and stress ulcers

Author: S. M. Tkach, Doctor of Medical Sciences, Chief Researcher of the Ukrainian Scientific and

Drug prevention and treatment of gastropathies associated with the use of non-steroidal anti-inflammatory drugs

Authors: E. V. Kolesnikova, T. A. Solomentseva, National Institute of Therapy named after L. T.

Selecting the Optimal Proton Pump Inhibitor for Patients with Coronary Artery Disease Who Require Dual Antiplatelet Therapy

Authors: O.O. Khaniukov, O.V. Pysarevska, M.G. Getman, T.A. Simonova, T.V. Lakiza, State Institution «Dnipropetrovsk Medical

The use of pantoprazole in the prevention of NSAID gastropathy

On the Ukrainian market, World Medicine presents the drug pantoprazole Ulsepan, which has proven its

ULSEPAN: pantoprazol 40 mg

The high efficacy of proton pump inhibitors (PPIs) makes this class of drugs one of

Аренда яхты